Urogen Pharma Ltd URGN 价格预测与展望

Q: 技术分析指标如何适用于 URGN？

根据技术分析，Urogen Pharma Ltd 的综合信号为 Sell。Urogen Pharma Ltd 有 2 个买入信号，0 个中性信号和 5 个卖出信号。

Q: URGN 的斐波那契回调水平是多少？

Urogen Pharma Ltd 的斐波那契回调水平是 低于100%的水平。

Q: Urogen Pharma Ltd 的 RSI 是多少？

Urogen Pharma Ltd 的 RSI 目前为 28.90，表明处于 超卖 状态

Q: Urogen Pharma Ltd 接下来 12 个月的价格是多少？

Urogen Pharma Ltd URGN 接下来 12 个月的价格预计为 $35.95。

Q: Urogen Pharma Ltd 预计会涨到多高？

据华尔街分析师称，Urogen Pharma Ltd 预计将达到 $57.75 的高预测值。

主页

股票

URGN

预测

URGN 股票价格预测

Urogen Pharma Ltd

$19.33

2.81%

$0.52

收盘价：Jan 20, 16:00:00 GMT-5

$19.5

0.87%

$0.17

盘后：Jan 20, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$18.8

开盘价

$18.2

当日区间

$18.2 - $19.5

52周范围

$3.42 - $30

交易量

560.4K

平均成交量

998.7K

每股收益（TTM）

-3.31

股息收益率

市值

$912.7M

什么是 URGN？

UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for URGN in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $35.95. The lowest target is $16.16 and the highest is $57.75. Empower your investment choices with our cutting-edge, data-driven analysis!

URGN 股价预测摘要

URGN的顶级分析师评级

基于 14 位分析师对 URGN 的股票评级，更新于 Sep 01, 2025

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for URGN. Our analysts highlight strong fundamentals and favorable market sentiment, positioning URGN for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: URGN is a Strong Buy candidate.

URGN stock price ended at $18.8 on 星期五, after dropping 3.79%

On the latest trading day Jan 16, 2026, the stock price of URGN fell by 3.79%, dropping from $19.33 to $18.80. During the session, the stock saw a volatility of 7.98%, with prices oscillating between a daily low of $18.66 and a high of $20.15. On the latest trading day, the trading volume for URGN decreased by 24.0K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.0M shares were traded, with a market value of approximately $880.0M.

URGN 技术面信号

技术面信号摘要

购买信号 2

中性信号 0

卖出信号 5

Strong Sell

Sell

Neutral

Buy

Strong Buy

URGN目前显示2个买入信号和5个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-3.79%。总体而言，技术指标显示中期前景为Sell。

URGN 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 URGN 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 URGN？



URGN 的斐波那契回调水平是多少？



Urogen Pharma Ltd 的 RSI 是多少？



Urogen Pharma Ltd 接下来 12 个月的价格是多少？



Urogen Pharma Ltd 预计会涨到多高？



Urogen Pharma Ltd（URGN）价格

URGN 股价走势图